RNTECH and DNAVision Announce Co-Marketing Agreement
News Feb 01, 2006
DNAVision and RNTECH have announced that they have signed a co-marketing agreement under which the companies will jointly offer an integrated package of high quality material biological bank, gene expression and genotyping technologies.
Post-genome era discovery processes must be based upon the combination of two key components: high quality, severely selected biological material associated with diagnostic and clinical data from large scale patient cohorts and platforms including genomics, proteomics and bioinformatics platforms.
The RNTECH/DNAVision offer associates these key components, creating an opportunity for pharmaceutical and biotechnology industries to access discovery and development expertise at an unparalleled level in oncology for biomarker and drugable target discovery and development.
"We are delighted to combine our extensive biological material bank in oncology with DNAVision’s gene expression and high-throughput genotyping platforms and offer, what we believe, a unique pharmacogenomic solution to pharmaceutical, clinical, and academic partners interested by finding new biomarkers in oncology," said Michael Bia, CEO of RNTECH.
"We believe that the quality of RNTECH’s biobank with complete clinical data and patient follow-up will provide in combination with our expertise a stronger, more clinically relevant offering for the oncology marketplace," said Jean-Pol Detiffe, CEO of DNAVision.
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018